Define range intervals using parentheses.
E.g. C7H(10-14)O(0-4)

to
±
(example: 123 ± 1)

to
±

to
±
 

to
±
 
Search Hits Limit:
Single/Multi-component
Isotopically Labeled
Additional Filters

Found 29 results

Search term: MF = 'C_{33}H_{39}ClN_{4}O_{6}'
12
IDStructureMolecular FormulaMolecular Weight# of Data Sources# of References# of PubMed# of RSC
67545

1 of 1 defined stereocentres - 1/1 defined
InChI=1/C33H38N4O6.ClH/c1-3-22-23-16-21(43-32(40)36-14-10-20(11-15-36)35-12-6-5-7-13-35)8-9-27(23)34-29-24(22)18-37-28(29)17-26-25(30(37)38)19-42-31(39)33(26,41)4-2;/h8-9,16-17,20,41H,3-7,10-15,18-19H2,1-2H3;1H/t33-;/m0./s1
C33H39ClN4O6623.1391031001993
317323

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C33H38N4O6.ClH/c1-3-22-23-16-21(43-32(40)36-14-10-20(11-15-36)35-12-6-5-7-13-35)8-9-27(23)34-29-24(22)18-37-28(29)17-26-25(30(37)38)19-42-31(39)33(26,41)4-2;/h8-9,16-17,20,41H,3-7,10-15,18-19H2,1-2H3;1H
C33H39ClN4O6623.1389599999981912900
28474899

1 of 1 defined stereocentres - 1/1 defined
InChI=1/C33H38N4O6.ClH/c1-3-22-23-16-21(43-32(40)36-14-10-20(11-15-36)35-12-6-5-7-13-35)8-9-27(23)34-29-24(22)18-37-28(29)17-26-25(30(37)38)19-42-31(39)33(26,41)4-2;/h8-9,16-17,20,41H,3-7,10-15,18-19H2,1-2H3;1H/t33-;/m1./s1
C33H39ClN4O6623.1399700
430274
InChI=1/C33H39ClN4O6/c1-32(2,3)44-31(41)37-10-8-33(9-11-37)21-38-20-26(30(40)35-18-22-4-6-24(34)7-5-22)29(39)25-16-23(17-27(43-33)28(25)38)19-36-12-14-42-15-13-36/h4-7,16-17,20H,8-15,18-19,21H2,1-3H3,(H,35,40)
C33H39ClN4O6623.1394300
9631194

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C33H38N4O6.ClH/c1-3-43-30(39)24-36-31(40)33(25-12-6-4-7-13-25,26-14-8-5-9-15-26)37(32(36)41)23-27(38)22-34-18-20-35(21-19-34)28-16-10-11-17-29(28)42-2;/h4-17,27,38H,3,18-24H2,1-2H3;1H
C33H39ClN4O6623.1393300
9752915

2 of 2 defined stereocentres - 2/2 defined
InChI=1/C33H39ClN4O6/c34-24-15-16-30(44-21-23-11-5-2-6-12-23)26(17-24)36-32(40)28-18-27(33(41)42)37-38(28)19-31(39)35-25-13-7-8-14-29(25)43-20-22-9-3-1-4-10-22/h1,3-4,9-10,15-18,23,25,29H,2,5-8,11-14,19-21H2,(H,35,39)(H,36,40)(H,41,42)/t25-,29-/m0/s1
C33H39ClN4O6623.1393200
107751403

2 of 2 defined stereocentres - 2/2 defined
InChI=1/C33H39ClN4O6/c1-22(39)36-13-10-24(11-14-36)32(42)38-17-27-26-4-2-5-28-31(26)44-21-33(27,20-38)19-35-29(40)18-37(12-3-15-43-28)30(41)16-23-6-8-25(34)9-7-23/h2,4-9,24,27H,3,10-21H2,1H3,(H,35,40)/t27-,33+/m0/s1
C33H39ClN4O6623.1393300
114990040

Double-bond stereo
InChI=1/C33H38N4O6.ClH/c1-7-20-19(6)32(42)37-27(20)14-25-18(5)23(10-12-31(40)41)29(35-25)15-28-22(9-11-30(38)39)17(4)24(34-28)13-26-16(3)21(8-2)33(43)36-26;/h13-15,35H,7-12H2,1-6H3,(H,36,43)(H,37,42)(H,38,39)(H,40,41);1H/b26-13u,27-14-,28-15?;
C33H39ClN4O6623.1392200
76803128

3 of 3 defined stereocentres - 3/3 defined
InChI=1/C33H39ClN4O6/c1-21(2)17-26(35-30(40)25-20-24(34)15-16-29(25)39)31(41)36-27(18-22-11-7-5-8-12-22)32(42)37-28(33(43)38(3)44-4)19-23-13-9-6-10-14-23/h5-16,20-21,26-28,39H,17-19H2,1-4H3,(H,35,40)(H,36,41)(H,37,42)/t26-,27-,28-/m0/s1
C33H39ClN4O6623.1392200
26383881

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C33H38N4O6.ClH/c1-3-43-29-17-11-10-16-28(29)35-20-18-34(19-21-35)22-27(38)23-37-32(41)36(24-30(39)42-2)31(40)33(37,25-12-6-4-7-13-25)26-14-8-5-9-15-26;/h4-17,27,38H,3,18-24H2,1-2H3;1H
C33H39ClN4O6623.1392200
26387093

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C33H38N4O6.ClH/c1-24(30(39)43-3)37-31(40)33(25-12-6-4-7-13-25,26-14-8-5-9-15-26)36(32(37)41)23-27(38)22-34-18-20-35(21-19-34)28-16-10-11-17-29(28)42-2;/h4-17,24,27,38H,18-23H2,1-3H3;1H
C33H39ClN4O6623.1392200
9687670

3 of 3 defined stereocentres - 3/3 defined
InChI=1/C33H39ClN4O6/c1-38-29(21-39)32(42)37-27(20-23-6-4-9-25(34)18-23)31(41)36-15-5-8-24-7-2-3-10-30(24)44-17-16-35-28(33(38)43)19-22-11-13-26(40)14-12-22/h2-4,6-7,9-14,18,27-29,35,39-40H,5,8,15-17,19-21H2,1H3,(H,36,41)(H,37,42)/t27-,28-,29-/m0/s1
C33H39ClN4O6623.1392100
24589342

1 of 1 defined stereocentres - 1/1 defined
InChI=1/C33H38N4O6.ClH/c1-3-22-23-9-8-21(43-32(40)36-14-10-20(11-15-36)35-12-6-5-7-13-35)16-27(23)34-29-24(22)18-37-28(29)17-26-25(30(37)38)19-42-31(39)33(26,41)4-2;/h8-9,16-17,20,41H,3-7,10-15,18-19H2,1-2H3;1H/t33-;/m0./s1
C33H39ClN4O6623.1391100
100587937

Double-bond stereo
InChI=1/C33H39ClN4O6/c1-33(2,3)44-32(40)38-17-15-37(16-18-38)19-20-42-28-10-5-24(6-11-28)22-35-36-31(39)25-7-14-30(41-4)26(21-25)23-43-29-12-8-27(34)9-13-29/h5-14,21-22H,15-20,23H2,1-4H3,(H,36,39)/b35-22-
C33H39ClN4O6623.1391100
104721845

Double-bond stereo
InChI=1/C33H39ClN4O6/c1-33(2,3)44-32(40)38-16-14-37(15-17-38)18-19-42-27-9-7-8-24(20-27)22-35-36-31(39)25-12-13-29(41-4)26(21-25)23-43-30-11-6-5-10-28(30)34/h5-13,20-22H,14-19,23H2,1-4H3,(H,36,39)/b35-22-
C33H39ClN4O6623.1391100
104722073

Double-bond stereo
InChI=1/C33H39ClN4O6/c1-33(2,3)44-32(40)38-17-15-37(16-18-38)19-20-42-29-11-7-5-9-25(29)22-35-36-31(39)24-13-14-28(41-4)26(21-24)23-43-30-12-8-6-10-27(30)34/h5-14,21-22H,15-20,23H2,1-4H3,(H,36,39)/b35-22-
C33H39ClN4O6623.1391100
121025931

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C33H39ClN4O6/c1-2-3-12-28(30(40)35-19-25-20-37(33(43)44-25)16-15-21-8-7-9-23(34)17-21)36-29(39)22-13-14-26-27(18-22)32(42)38(31(26)41)24-10-5-4-6-11-24/h7-9,13-14,17-18,24-25,28H,2-6,10-12,15-16,19-20H2,1H3,(H,35,40)(H,36,39)
C33H39ClN4O6623.1391100
59760874

Double-bond stereo
InChI=1/C33H38N4O6.ClH/c1-7-20-19(6)32(42)37-27(20)14-25-18(5)23(10-12-31(40)41)29(35-25)15-28-22(9-11-30(38)39)17(4)24(34-28)13-26-16(3)21(8-2)33(43)36-26;/h13-15,35H,7-12H2,1-6H3,(H,36,43)(H,37,42)(H,38,39)(H,40,41);1H/b26-13+,27-14-,28-15?;
C33H39ClN4O6623.1391100
68911407

Double-bond stereo
InChI=1/C33H38N4O6.ClH/c1-7-20-19(6)32(42)37-27(20)14-25-18(5)23(10-12-31(40)41)29(35-25)15-28-22(9-11-30(38)39)17(4)24(34-28)13-26-16(3)21(8-2)33(43)36-26;/h13-15,35H,7-12H2,1-6H3,(H,36,43)(H,37,42)(H,38,39)(H,40,41);1H/b26-13-,27-14-,28-15?;
C33H39ClN4O6623.1391100
12

Advertisement